Neurava

Baltimore, United States

Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP.

$1.6M raised

Apr 2026

Grant

Top Investors

Union Chimique BelgeElevate VenturesMassChallengeMedTech InnovatorLife Science Angels

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Neurava raised?

Neurava has raised $1.6M in total funding. The most recent round was Grant. The last funding was announced in April 2026.

Who are Neurava's investors?

Neurava's investors include Union Chimique Belge, Elevate Ventures, MassChallenge, MedTech Innovator, Life Science Angels.

Where is Neurava headquartered?

Neurava is headquartered in Baltimore, United States.

What does Neurava do?

Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP.

What stage is Neurava at?

Neurava is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 23, 2026.

MLA

"Neurava — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/neurava. Accessed June 3, 2026.

APA

VCBacked. (2026). Neurava — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/neurava

Wikipedia (cite web)

{{cite web |title=Neurava — Funding & Investors |url=https://www.vcbacked.co/company/neurava |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 23, 2026.